These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 37968405)

  • 21. Functional CRISPR screens in T cells reveal new opportunities for cancer immunotherapies.
    Xiang M; Li H; Zhan Y; Ma D; Gao Q; Fang Y
    Mol Cancer; 2024 Apr; 23(1):73. PubMed ID: 38581063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Schrödinger's T Cells: Molecular Insights Into Stemness and Exhaustion.
    Gonzalez NM; Zou D; Gu A; Chen W
    Front Immunol; 2021; 12():725618. PubMed ID: 34512656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multi-Omics Atlas-Assisted Discovery of Transcription Factors for Selective T Cell State Programming.
    Chung HK; Liu C; Jambor AN; Riesenberg BP; Sun M; Casillas E; Chick B; Wang J; Ma S; Mcdonald B; He P; Yang Q; Chen T; Varanasi SK; LaPorte M; Mann TH; Chen D; Hoffmann F; Tripple V; Ho J; Cho UH; Modliszewski J; Williams A; Liu L; Wang Y; Hargreaves DC; Thaxton JE; Kaech SM; Wang W
    bioRxiv; 2024 Sep; ():. PubMed ID: 36711632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decitabine priming increases anti-PD-1 antitumor efficacy by promoting CD8+ progenitor exhausted T cell expansion in tumor models.
    Li X; Li Y; Dong L; Chang Y; Zhang X; Wang C; Chen M; Bo X; Chen H; Han W; Nie J
    J Clin Invest; 2023 Apr; 133(7):. PubMed ID: 36853831
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo CRISPR screens reveal the landscape of immune evasion pathways across cancer.
    Dubrot J; Du PP; Lane-Reticker SK; Kessler EA; Muscato AJ; Mehta A; Freeman SS; Allen PM; Olander KE; Ockerman KM; Wolfe CH; Wiesmann F; Knudsen NH; Tsao HW; Iracheta-Vellve A; Schneider EM; Rivera-Rosario AN; Kohnle IC; Pope HW; Ayer A; Mishra G; Zimmer MD; Kim SY; Mahapatra A; Ebrahimi-Nik H; Frederick DT; Boland GM; Haining WN; Root DE; Doench JG; Hacohen N; Yates KB; Manguso RT
    Nat Immunol; 2022 Oct; 23(10):1495-1506. PubMed ID: 36151395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The development of CD8 T-cell exhaustion heterogeneity and the therapeutic potentials in cancer.
    Zhang J; Lei F; Tan H
    Front Immunol; 2023; 14():1166128. PubMed ID: 37275913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
    Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
    Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T-cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma.
    Barsch M; Salié H; Schlaak AE; Zhang Z; Hess M; Mayer LS; Tauber C; Otto-Mora P; Ohtani T; Nilsson T; Wischer L; Winkler F; Manne S; Rech A; Schmitt-Graeff A; Bronsert P; Hofmann M; Neumann-Haefelin C; Boettler T; Fichtner-Feigl S; van Boemmel F; Berg T; Rimassa L; Di Tommaso L; Saeed A; D'Alessio A; Pinato DJ; Bettinger D; Binder H; John Wherry E; Schultheiss M; Thimme R; Bengsch B
    J Hepatol; 2022 Aug; 77(2):397-409. PubMed ID: 35367533
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic abrogation of immune checkpoints in antigen-specific cytotoxic T-lymphocyte as a potential alternative to blockade immunotherapy.
    Zhang C; Peng Y; Hublitz P; Zhang H; Dong T
    Sci Rep; 2018 Apr; 8(1):5549. PubMed ID: 29615718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Antiviral Cytotoxic CD4 T Cell Differentiation.
    Knudson CJ; Férez M; Alves-Peixoto P; Erkes DA; Melo-Silva CR; Tang L; Snyder CM; Sigal LJ
    J Virol; 2021 Sep; 95(19):e0056621. PubMed ID: 34260270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade.
    Pauken KE; Sammons MA; Odorizzi PM; Manne S; Godec J; Khan O; Drake AM; Chen Z; Sen DR; Kurachi M; Barnitz RA; Bartman C; Bengsch B; Huang AC; Schenkel JM; Vahedi G; Haining WN; Berger SL; Wherry EJ
    Science; 2016 Dec; 354(6316):1160-1165. PubMed ID: 27789795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo CRISPR screening reveals nutrient signaling processes underpinning CD8
    Huang H; Zhou P; Wei J; Long L; Shi H; Dhungana Y; Chapman NM; Fu G; Saravia J; Raynor JL; Liu S; Palacios G; Wang YD; Qian C; Yu J; Chi H
    Cell; 2021 Mar; 184(5):1245-1261.e21. PubMed ID: 33636132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive profile of TCF1
    Wang D; Fang J; Wen S; Li Q; Wang J; Yang L; Dai W; Lu H; Guo J; Shan Z; Xie W; Liu X; Wen L; Shen J; Wang A; Chen Q; Wang Z
    Int J Oral Sci; 2022 Feb; 14(1):8. PubMed ID: 35153298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor-β-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection.
    Gabriel SS; Tsui C; Chisanga D; Weber F; Llano-León M; Gubser PM; Bartholin L; Souza-Fonseca-Guimaraes F; Huntington ND; Shi W; Utzschneider DT; Kallies A
    Immunity; 2021 Aug; 54(8):1698-1714.e5. PubMed ID: 34233154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ectopic Tcf1 expression instills a stem-like program in exhausted CD8
    Shan Q; Hu S; Chen X; Danahy DB; Badovinac VP; Zang C; Xue HH
    Cell Mol Immunol; 2021 May; 18(5):1262-1277. PubMed ID: 32341523
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental Relationships of Four Exhausted CD8
    Beltra JC; Manne S; Abdel-Hakeem MS; Kurachi M; Giles JR; Chen Z; Casella V; Ngiow SF; Khan O; Huang YJ; Yan P; Nzingha K; Xu W; Amaravadi RK; Xu X; Karakousis GC; Mitchell TC; Schuchter LM; Huang AC; Wherry EJ
    Immunity; 2020 May; 52(5):825-841.e8. PubMed ID: 32396847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of CD4 T cells on intratumoral CD8 T-cell exhaustion and responsiveness to PD-1 blockade therapy in mouse brain tumors.
    Khan SM; Desai R; Coxon A; Livingstone A; Dunn GP; Petti A; Johanns TM
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36543376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inference of Developmental Hierarchy and Functional States of Exhausted T Cells from Epigenetic Profiles with Deep Learning.
    Chen H; Yan D; Sun J; Zhou M
    J Chem Inf Model; 2024 Apr; 64(8):3579-3591. PubMed ID: 38545680
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer CRISPR Screens In Vivo.
    Chow RD; Chen S
    Trends Cancer; 2018 May; 4(5):349-358. PubMed ID: 29709259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen-specific tumor cell killing by cytotoxic T cells.
    Herzfeldt AK; Gamez MP; Martin E; Boryn LM; Baskaran P; Huber HJ; Schuler M; Park JE; Swee LK
    Elife; 2023 Sep; 12():. PubMed ID: 37732732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.